DRAP allows import, manufacturing of Remdesivir 22 Jun, 2020
ISLAMABAD-Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of Remdesivir used for critically ill patients of COVID-19. According to spokesman Ministry of National Health Services, on increasing demand, approvals are issued to two importers ...